Objective-To assess the prevalence and significance of enteroviral genome within myocardial biopsy specimens taken from patients with idiopathic dilated cardiomyopathy and from controls.
Setting-A tertiary referral centre for patients with idiopathic dilated cardiomyopathy.
Patients-Tissue for the study came from 50 consecutive patients with dilated cardiomyopathy, 41 with other forms of heart disease and 34 from coroners' necropsy cases.
Results-Enteroviral genome was detected in 6150 (12%) patients with dilated cardiomyopathy and 13/75 (17%) of the controls (not significant). No differences were seen between dilated cardiomyopathy patients with or without myocardial enteroviral genome in respect of age; duration of symptoms; proportion of patients with a premorbid acute viral illness, excess alcohol consumption, or hypertension; New York Heart Association functional class; measures of left ventricular function; or endomyocardial histology. Within the control group enteroviral genome was detected in 3/15 (20%) patients with ischaemic heart disease, 2/19 (10-5%) with valvar heart disease, 1/5 (20%) with specific heart muscle disease, 0/2 (0%) with congenital heart disease, and 7/34 (20-6%) cases of sudden death. During 2-52 month follow up (mean 22) 15144 (34%) patients without myocardial enteroviral genome and 2/6 (33%) with myocardial enteroviral genome died suddenly or required orthotopic heart transplantation for progressive heart failure.
Conclusions-These findings do not support the hypothesis that persistent enteroviral infection is of pathogenic or prognostic importance in dilated cardiomyopathy but they are consistent with enterovirus being a common environmental pathogen.
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CONTROL PATIENTS
Enterovirus-specific gene amplification by polymerase chain reaction was noted in 13/75 (17-3%) of the control population. This was not significantly different when compared with the results of the dilated cardiomyopathy patients. Subgroup analysis showed the presence of myocardial enteroviral genome in 2/19 (10-5%) with valvar heart disease, 3/15 (20%) with ischaemic heart disease, 1/5 (20%) with specific heart muscle diseases, 0/2 (0%) with congenital heart disease, and 7/34 (20.6%) community sudden deaths including 3/12 (25%) cases who died from myocardial infarction.
Discussion
In this study we applied a highly sensitive and specific polymerase chain reaction technique to detect enteroviral genome in myocardial tissue taken from 50 patients with dilated cardiomyopathy and from 75 controls (41 with other forms of heart disease and 34 from coroners' necropsy cases). Enteroviral genome was detected within the myocardium in 6/50 (12%) patients with dilated cardiomyopathy but was not associated with any feature of clinical, histological, or functional assessment. Furthermore, the presence of enteroviral genome within the myocardium of these patients did not confer on them an adverse prognosis as has been proposed.25 Our study also showed that enteroviral genome was present in myocardial tissues in a similar proportion of controls (17%).
All the patients studied with dilated cardiomyopathy have been extensively characterised with strict diagnostic criteria and are being regularly followed up. The control tissues were taken either at the time of cardiac catheterisation or surgery or from coroners' necropsies. The quality of the extracted ribonucleic acid, a particular concern for the necropsy tissues because of its possible degradation after death, was found to be adequate in all groups of patients. The polymerase chain reaction used in this study was highly sensitive and capable of detecting as few as 100 copies of enteroviral genome within a single endomyocardial biopsy specimen. The hybridisation probe (E3) used has previously been shown to be pan-enteroviral and capable of detecting a wide range of enteroviruses.23
Some non-specific hybridisation with genomic ribonucleic acid or complementary deoxyribonucleic acid was noted but this was easily distinguished from enteroviral specific hybridisation after gel electrophoresis and southern blotting of the amplification product.
We found enteroviral genome within the myocardium of 12% of patients with dilated cardiomyopathy: similar proportions were reported by other workers who used in situ hybridisation" 2 PJK is a British Heart Foundation research fellow and ALPC is supported by a research fellowship from the European Society of Cardiology. We also acknowledge the helpful comments of Dr Steve Tracy with regard to the ribonucleic acid amplification.
